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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not
hydrotherapy improves health-related quality of life (HR-QoL) in adult men and women with
multiple sclerosis (MS).
Study Design: Review of three randomized controlled trials (RCTs) published between 2012current, all in the English language.
Data Sources: Three randomized controlled trials (RCTs), all of which evaluate the
effectiveness of hydrotherapy compared to a control group that was asked either not to change
their exercise habits or to participate in land-based activities. All studies were found using
PubMed and Embase.
Outcomes Measured: Each of the three articles analyzed the effects of hydrotherapy on
improving health-related quality of life. The Short form-36 (SF-36), Multiple Sclerosis Quality
of Life-54 (MSQOL-54), and Multiple Sclerosis Impact Scale-29 (MSIS-29) were the
questionnaires used to measure HR-QoL.
Results: The studies by Castro-Sanchez et al.7 and Kargarfard et al.5 found that hydrotherapy
significantly improved HR-QoL in adult MS patients compared to the control group. The study
by Bansi et al.8 was inconclusive because HR-QoL improved both in the experimental and
control group, with no significant difference between the two.
Conclusions: Hydrotherapy was shown to improve HR-QoL in all three studies. However, in
one study, HR-QoL improved independent of the therapy used, with no significant difference
between the hydrotherapy and land-based exercise groups.8 Therefore, evidence is inconclusive.
Keywords: Multiple Sclerosis, Hydrotherapy
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INTRODUCTION
Multiple sclerosis is an immune-mediated relapsing-remitting or progressive
demyelinating disease of the CNS characterized by chronic inflammation, gliosis, and neuronal
loss.1 The exact cause of MS is unknown. Risk factors include vitamin D deficiency, exposure to
Epstein-Barr virus after early childhood, and cigarette smoking.1 Symptoms vary greatly from
person to person and can range from asymptomatic to severe disease. Characteristic symptoms
include exercise-induced weakness, optic neuritis, and heat sensitivity. Other common symptoms
include spasticity, diplopia, paresthesias, ataxia, bladder dysfunction, depression, and fatigue.
There are approximately 2.3 million individuals worldwide and 350,000 people in the
United States with MS1, but there has not been a scientific, national study of prevalence since
1975.2 Hospital admissions for MS are increasing, with the most recent data showing 102,473 ±
3,485 in 2001, rising to 144, 716 ± 3,902 admissions in 2010.3 Total costs for all people with MS
in the U.S. is approximately $28 billion annually.4 Annual costs, including both direct and
indirect costs for a patient with MS in the U.S. is approximately $69,000.4 Approximately
$39,000 consists of health care costs.4
There is no cure for MS, only medications and other therapies to control symptoms,
prevent exacerbations and slow the progression of the disease. Therefore, different forms of
complementary and alternative medicine (CAM) are important considerations to reduce
symptoms and improve daily functioning for MS patients. The mainstay of treatment for acute
attacks is glucocorticoids. Plasma exchange can be used if the patient is refractory to steroids.
Maintenance treatment can be achieved with disease-modifying agents that are injectable
medications, such as IFN-β-1a (Avonex) and IFN-β-1a (Rebif); oral medications, such as
fingolimod (Gilenya) and teriflunomide (Aubagio); or infused medications, such as mitoxantrone
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(Novantrone) and alemtuzumab (Lemtrada).1 Aside from medications, comprehensive care of
MS includes PT/OT, cognitive rehabilitation, vocational rehabilitation, and speech-language
pathology. The goal of these treatment modalities is to improve and maintain function and to
increase the quality of life for MS patients.
With no definitive cure for MS, additional treatment modalities, including hydrotherapy,
are being researched to determine their efficacy in improving the symptoms of MS.
Hydrotherapy, also known as water therapy, aquatic therapy, pool therapy, and balneotherapy, is
a type of alternative medicine that uses water in various ways to provide therapeutic effects. It is
thought that the cooling effect of the water may help MS patients since the neurological
symptoms associated with MS can be produced by an elevation in the body’s core temperature.1
The potential benefits from hydrotherapy are based on the ideas that the pool water can reduce
the body temperature and increase exercise tolerance compared to land-based exercise.5 It is also
thought that the buoyancy of the water can decrease resistance against the body, allowing
patients to endure longer periods of physical activity with less resulting fatigue.5 A study in 2011
has found that walking is the most common type of physical activity reported by patients with
MS, followed by gardening and weight training.6 Hydrotherapy may be a new promising
recommendation by health care providers over traditional land-based exercises if the research
supports its use. This paper evaluates three randomized controlled trials analyzing the effects of
hydrotherapy as an adjunctive treatment for men and women with multiple sclerosis.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not hydrotherapy
improves health-related quality of life (HR-QoL) in adult men and women with multiple
sclerosis (MS).
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METHODS
The criteria used for the selection of the three RCT studies in this systematic review was
based on the population demographics, interventions utilized, and the outcomes measured. The
populations studied in these RCTs were men and women over the age of 18 with a formal
diagnosis of multiple sclerosis. The intervention being studied is hydrotherapy. The control
groups in two of the studies consisted of land-based exercises, including a land cycle ergometer
and abdominal breathing combined with contraction-relaxation exercises. The third study
utilized a control group that did not have any additional exercise requirements and were asked to
make no changes to their normal routine. Health-related quality of life (HR-QoL) is the outcome
being measured by these studies using patient-oriented evidence.
Research for this systematic review was collected using Pubmed and Embase to find
randomized controlled trials in peer-reviewed journals that were published no earlier than 2006.
All three articles were published in the English language. Articles were selected based on their
relevance to the objective of this systematic review and if outcomes measured were POEMs
(patient-oriented evidence that matters). The keywords used to search for relevant articles were
“multiple sclerosis” and “hydrotherapy”. The inclusion criteria for this systematic review
required that patients were men and women over the age of 18. Anyone under the age of 18 and
anyone who recently relapsed were excluded. Refer to Table 1 for inclusion and exclusion
criteria specific to each of the three studies. These studies analyzed data using t-tests and
ANOVA. Values reported were mean change from baseline, p-values, and confidence intervals.
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Table 1 - Demographics & Characteristics of included studies
Study

#Pts Age
(yrs)
Randomized 60
46-56
Controlled
years
Trial
old

Inclusion
Criteria
Patients with
MS diagnosis
with EDSS
between 1.06.5

Randomized 73
Controlled
Trial

18-75
years
old

Patients 1875 years old
with MS
diagnosis
who have
VAS pain
score > 4 for
at least 2
months and
EDSS ≤ 7.5

Kargarfa Randomized 32
rd5
Controlled
(2012)
Trial

Avg
age =
32.6

Women with
diagnosis of
MS for ≥ 2
years, no
relapse
within the 4
weeks prior,
ability to
participate,
EDSS ≤ 3.5

Bansi8
(2013)

CastroSanchez
7
(2012)

Type

Exclusion
Criteria
Patients were
excluded if
incontinence,
persistent
infections,
cardiovascula
r and
pulmonary
diseases, or if
immunosuppr
essive
therapy was
existent.
Treatment
with another
CAM
(complementa
ry &
alternative
medicine)
currently or
within past 3
months,
relapse or
steroid
treatment
within the
past 2 months
Relapse
during
intervention
period,
comorbidities
(cardiovascul
ar,
pulmonary,
skeletal
disease)

W/
D
8

Interventions

2

Twice-weekly
20-week AiChi aquatic
exercise
program

11

60 minute
aquatic
exercise
program three
times per
week x8
weeks

Daily 30
minute
endurance
training on an
aquatic bike
x3 weeks
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OUTCOMES MEASURED
The outcome measured in these studies was health-related quality of life (HR-QoL),
which looks at physical, mental, emotional and social functioning, focusing on how quality of
life is impacted by health status. Castro-Sanchez et al. assessed HR-QoL using the MSIS-29
scale.7 This scale measures HR-QoL using a 29-item self-report measure associated with a
physical and psychological scale that questions patients about the impact MS has on their day-today lives. Kargarfard et al. assessed HR-QoL using the Multiple Sclerosis Quality of Life-54
(MSQOL-54), which consists of 54 items that are designed to measure composite scores for
physical and mental health.5 Composite scores are determined using subscales, which assess
physical function, physical and emotional role limitation, pain, emotional well-being, energy,
health perceptions, social function, cognitive function, health distress, overall quality of life, and
sexual function.5 Higher scores indicate better HR-QoL. Bansi et al. used the Short Form-36 (SF36) to assess HR-QoL, which looks at physical, mental and social aspects of health and how they
impact quality of life for MS patients.8
RESULTS
Three randomized controlled trials were used to determine if hydrotherapy served as an
effective treatment to improve HR-QoL in MS patients over the age of 18. Data from these
studies were continuous data and could not be converted to dichotomous form. Therefore, results
evaluating treatment efficacy could not be calculated.
Castro-Sanchez et al.7 followed 73 patients, with 36 patients in the experimental group
(26 females) and 37 patients in the control group (24 females). Two patients in the control group
were excluded due to relapse. Power calculations were performed, estimating a minimal sample
size of 33 participants per group for a power of 80% and standard deviation (SD) of 3.1. There
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was no significant difference in demographic characteristics between the groups. The
intervention for the experimental group was an Ai-Chi exercise program conducted in a
swimming pool with a water temperature of 36 °C. Exercises included a combination of deep
breathing and broad movements of the arms, legs, and torso to work on strength, balance,
flexibility, relaxation, and breathing. Tai-Chi music was also played during the sessions, which
lasted 60 minutes each. The intervention for the control group consisted of exercise sessions that
were conducted on land in a therapy room with a temperature of 26 °C. The patients underwent
the same exercise program as the experimental group. No music was played during these
sessions. The sessions were led by the same physiotherapist for the experimental and control
groups. Both groups received treatment twice a week for 20 weeks. There was follow-up at
weeks 24 and 30. For the purpose of this systematic review, focus will be on effects immediately
post-treatment at 20 weeks. HR-QoL was measured using two scales. Using the MSIS-29
Physical scale, there was a significant improvement in HR-QoL in the experimental group at
week 20 (P < 0.013) that was also maintained at follow-up at weeks 24 (P<0.017) and 30
(P<0.025). The control group showed no significant difference in HR-QoL at any time point
during the study. As shown in Table 3, there were significant differences between the
experimental and control groups at week 20 (P<0.014), as well as at follow-up at week 24
(P<0.019) and week 30 (P<0.027). Using the MSIS-29 Psychological scale, both the
experimental and control group showed a significant improvement in HR-QoL at week 20 (P <
0.009 and P<0.046, respectively) that was maintained at the week 24 and week 30 follow-up.
There were significant differences between the experimental and control group at week 20
(P<0.023), as well as at week 24 follow-up (P<0.027) and week 30 follow-up (P<0.038), as
shown in Table 3. This data demonstrates effects on HR-QoL that were superior in the
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experimental group compared to the control group.7
Table 2. Median and standard deviation values at baseline and week 20 with associated p-values
MSIS-29 Physical

MSIS-29 Psychological

Experimental

Control

Experimental

Control

Week 0

Median = 48
St. dev = 15.91

Median = 46
St. dev = 18.34

Median = 34
St. dev = 29.47

Median = 30
St. dev = 23.53

Week 20

Median = 41
St. dev = 12.37

Median = 45
St. dev = 17.14

Median = 21
St. dev = 15.73

Median = 25
St. dev = 19.36

% change
from baseline

78%
improvement

6%
improvement

81%
improvement

37%
improvement

p-value

P<0.013

P<0.05

P <0.009

P <0.046

Table 3. Median (SD) MSIS-29 scores, Comparing experimental and control groups at week 20
Group

Median (St. deviation)

P-value

MSIS-29 Physical
Experimental
Control

41 (12.37)
45 (17.14)
MSIS-29 Psychological

Experimental

21 (15.73)

Control

25 (19.36)

P<0.014

P<0.023

Kargarfard et al.5 recruited 32 women with relapsing-remitting MS into their study. Six
patients from the exercise group and five patients from the control group were excluded from
analysis due to relapse, personal circumstances, being unable to regularly participate in exercise
training, or refusing to participate in measurement of outcomes at both 4 and 8 weeks. A
sensitivity analysis was performed, which showed that the results of statistical significance were
the same whether ITT or complete data were employed. Therefore, the results presented here are
based on 21 patients, with 10 from the experimental group and 11 from the control group. There
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was no significant difference in demographic characteristics between the groups. The
intervention for the experimental group was a 60-minute aquatic exercise program three times
per week for 8 weeks. The aquatic exercise took place in a swimming pool at a temperature
maintained between 28-30°C. Exercises included those that focused on joint mobility, muscle
strength, balance and posture, along with functional activities and intermittent walking. The
control group was asked to maintain their current treatment and behavior over the 8 weeks. The
Multiple Sclerosis Quality of Life-54 (MSQOL-54) scale was used to assess HR-QoL using two
subscales, MSQOL-54-physical and MSQOL-54-mental. For MSQOL-54-physical and
MSQOL-54-mental, the control group showed no significant difference from baseline to week 8.
The experimental group did show a statistically significant difference in HR-QoL from baseline
to week 8 for MSQOL-54-physical (P<0.001) and MSQOL-54-mental (P<0.001). Refer to Table
4 for intragroup statistics and P values. Additionally, MSQOL-54-physical and MSQOL-54mental scores were significantly different between the experimental and control groups at week 8
to the favor of the experimental group. Refer to Table 5 for intergroup statistics and P-values.5

Table 4. Pairwise comparisons examining quality of life at baseline and 8 weeks with data
expressed as mean differences ± SE
MSQOL-54-Physical

Difference
between
baseline and 8
weeks
p-value

MSQOL-54-Mental

Experimental

Control

Experimental

Control

21.5 ± 1.7

0.7 ± 1.0

25.8 ± 3.1

1.1 ± 1.6

P<0.001

P>0.05

P <0.001

P >0.05
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Table 5. Comparison of quality of life between experimental and control groups at week 8
Group
Mean ± SD
P-value
MSQOL-54-Physical
Experimental

65.4 ± 6.6

Control

44.2 ± 4.4
MSQOL-54-Mental

Experimental

70.2 ± 5.7

Control

43.6 ± 8.9

P<0.001

P<0.001

Bansi et al.8 followed 52 patients, with 24 patients in the experimental group and 28
patients in the control group. Sixty patients were initially included in the study, but eight had
been excluded due to immunosuppressive therapy being given during the study or inability to
comply with the daily schedule of activities. There was no significant difference in demographic
characteristics between the groups. The intervention for the experimental group was daily 30minute endurance training sessions on an aquatic bike for 3 weeks. Water temperature was held
constant at 28 °C. The control group participated in daily 30-minute endurance training sessions
on land cycle ergometers for 3 weeks. The Short form-36 (SF-36) was used to assess HR-QoL in
this study. Both the experimental and control groups showed a statistically significant difference
in SF-36 scores over the 3 weeks, as shown in Table 6. SF-36 scores did not show statistically
significant group differences over the 3 week training period. There were beneficial effects on
HR-QoL independent of the training setting. Refer to Table 6 for P-values.8
Table 6. Time and group effects for the experimental and control group over 3 weeks

SF-36 Total
Score

t1

Time point
Mean (95% CI)
t2
Difference t2 – t1

ANOVA p values
Time

Group
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Experimental 59.3 (50.8-68.2) 63.4 (55.7-71.7) 4.2 (-9.2 to 0.8)
Group
Control
Group

53.9 (46.3-61.4) 58.4 (50.1-66.5) 4.46 (-9.3 to 0.4)

0.031
0.031

0.766

No adverse events related to the interventions utilized in these studies were reported. In
the study by Kargarfard et al.5, lifeguards and pool safety equipment were available at all times.
Also, patients were allowed to use a noodle or foam hand bars while performing exercises in this
study.5 Hydrotherapy is a safe intervention with no obvious adverse effects related to its use.
DISCUSSION
This systematic review explored the efficacy of hydrotherapy as an adjunctive treatment
for patients with MS to improve health-related quality of life. The studies by Castro-Sanchez et
al.7 and Kargarfard et al.5 showed significant improvements in HR-QoL, with no adverse effects
noted. The third study by Bansi et al.8 showed improvement in HR-QoL independent of the type
of exercise therapy.
There were several limitations to these studies. In the study by Castro-Sanchez et al.7, the
hydrotherapy group had the addition of ambient music during their training sessions, while the
control group had no ambient music played during their land-based exercise training sessions.
The contributions of this factor should be further explored. For the same study, it could not be
guaranteed that participants were blinded to the nature of their group since they all belonged to
the same organization. Generally speaking, there is a need for studies with larger sample sizes;
the largest sample size in a study utilized in this systematic review was 71. Lastly, the time factor
varied among the studies, with the effects of hydrotherapy measured from a range of 3 weeks –
30 weeks. It would be beneficial to measure effects of the therapy over a longer duration of time.
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Hydrotherapy does have limitations to its use. The cost could be a deterrent to patients
who are on a budget. Insurance coverage for hydrotherapy varies, and paying out of pocket could
easily add up over time. Some insurance companies, such as BlueCross BlueShield, require
hydrotherapy to be administered by a certified physical therapist. Various insurance plans will
not cover group exercise programs, but rather one on one sessions with a licensed provider.
Additionally, only a certain number of sessions may be covered, which could lead to cessation of
therapy before full effects of the treatment have been achieved.
No contraindications were defined in the research regarding the use of hydrotherapy.
CONCLUSIONS
Based on the current research available, the evidence is inconclusive on whether
hydrotherapy improves HR-QoL in adult men and women with MS. Two out of the three studies
show significant improvement in HR-QoL using hydrotherapy compared to the control group.5,7
While the third study showed improvement in HR-QoL in both the group receiving hydrotherapy
and the control group, there was no statistically significant difference between the two groups.8
With this in mind, MS requires a multidisciplinary approach. With no notable adverse effects,
hydrotherapy can be considered a safe alternative to traditional land-based exercise.
There has been limited research on this topic, and further studies are warranted. With
hydrotherapy being a broad term, the actual exercise regimens used varied greatly from study to
study. In the two studies that showed improvement in HR-QoL, hydrotherapy consisted of
exercises defined by various movements performed while standing in the water. The study that
had inconclusive evidence to the benefits of hydrotherapy utilized an underwater bike for
training sessions. It could be beneficial for future studies to focus on a more standardized
exercise routine to have a more exact definition across the board of what hydrotherapy entails.
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